Receive Breaking News updates as they occur
Aspirin can reduce the risk of colon cancer by half, but only in people who carry high levels of a specific type of gene, a study released Wednesday found. Researchers previously were aware that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin could reduce colorectal cancer risks, but they did not understand why some saw a benefit and others did not, according to the study in Science Translational Medicine. Scientists studied tissues from people who developed colon cancer while on an aspirin regimen then set out to understand why people with a particular gene appeared to get a protective benefit from aspirin and others did not. They examined tissues of 270 colon cancer patients from 127,865 participants followed for over three decades.
British retail sales edged up unexpectedly in March, official data showed on Friday, suggesting consumers are still at the forefront of Britain's strong economic recovery. Retail sales volumes rose 0.1 percent on the month to show 4.2 percent growth on the year, the Office for National Statistics said. Economists taking part in a Reuters poll had expected retail sales to slip 0.4 percent on the month, owing in part to the Easter holidays falling in April this year, and after strong growth of 1.3 percent in February, which was downwardly revised. Consumers, many of them buoyed by a strengthening housing market, have so far been the main driving force behind Britain's rapid economic recovery.